(Q37938836)

25 August 2017

1 reference

title

Predictors of statin adherence (English)

1 reference

25 August 2017

Alexander Mauskop

1

1 reference

25 August 2017

William B Borden

series ordinal

2

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Current cardiology reports

25 August 2017

published in

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

553-558

1 reference

Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Beyond "compliance" is "adherence". Improving the prospect of diabetes care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Predictors of nonadherence to statins: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Patient, physician, and payment predictors of statin adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Use of statins and beta-blockers after acute myocardial infarction according to income and education

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Provider adherence to clinical guidelines related to lipid-lowering medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Clinical outcomes and adherence to medications measured by claims data in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Long-term adherence to statin treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0221-2

Physician Follow-up and Provider Continuity Are Associated With Long-term Medication Adherence

21 January 2018

1 reference

12 December 2020

Impact of statin copayments on adherence and medical care utilization and expenditures

1 reference

12 December 2020

Benefits of statin therapy and compliance in high risk cardiovascular patients

1 reference

12 December 2020

Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations

1 reference

12 December 2020

Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

10.1007/S11886-011-0221-2

Identifiers

DOI

1 reference

25 August 2017

1 reference